Daiichi Suntory Pharma (Rights To 6R-BH4)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
A drug development and marketing right in Japan. The drug development right is associated to treat cardiovascular indications and genetic disease phenylketonuria (PKU).
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
- Daiichi Sankyo Building A/B 3-5-1
- Nihonbashi-honcho
- Tokyo, 103-8426
- Japan
Daiichi Suntory Pharma (Rights To 6R-BH4) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Daiichi Suntory Pharma (Rights To 6R-BH4)‘s full profile, request access.
Request full access to PitchBookDaiichi Suntory Pharma (Rights To 6R-BH4) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Daiichi Suntory Pharma (Rights To 6R-BH4)‘s full profile, request access.
Request full access to PitchBook